for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Baxter International Inc

BAX.N

Latest Trade

78.18USD

Change

-1.52(-1.91%)

Volume

644,292

Today's Range

77.96

 - 

79.60

52 Week Range

73.13

 - 

88.31

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
79.70
Open
79.60
Volume
644,292
3M AVG Volume
70.31
Today's High
79.60
Today's Low
77.96
52 Week High
88.31
52 Week Low
73.13
Shares Out (MIL)
499.91
Market Cap (MIL)
39,842.85
Forward P/E
22.61
Dividend (Yield %)
1.41

Next Event

Q3 2021 Baxter International Inc Earnings Release

Latest Developments

More

Baxter International Inc Entered Into A New Term Loan Credit Agreement

Baxter Announces U.S. FDA Approval And Launch Of Ready-To-Use Cardiovascular Medicine Norepinephrine In Premix Formulation

Baxter Issues Urgent Medical Device Correction To Reinforce Safety Information For Dose IQ Safety Software Desktop Application V.9.0X

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Baxter International Inc

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

Industry

Medical Equipment & Supplies

Contact Info

1 Baxter Pkwy

DEERFIELD, IL

60015-4625

United States

+1.847.9482000

https://www.baxter.com/

Executive Leadership

Jose E. Almeida

Chairman of the Board, President, Chief Executive Officer

James K. Saccaro

Chief Financial Officer, Executive Vice President

Sean B. W. Martin

Senior Vice President, General Counsel

Jeanne K. Mason

Senior Vice President - Human Resources

Giuseppe Accogli

Senior Vice President, President - America

Key Stats

2.13 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

11.1K

2019

11.4K

2020

11.7K

2021(E)

12.6K
EPS (USD)

2018

3.050

2019

3.310

2020

3.090

2021(E)

3.525
Price To Earnings (TTM)
36.55
Price To Sales (TTM)
3.27
Price To Book (MRQ)
4.69
Price To Cash Flow (TTM)
20.00
Total Debt To Equity (MRQ)
72.60
LT Debt To Equity (MRQ)
67.22
Return on Investment (TTM)
6.89
Return on Equity (TTM)
5.78

Latest News

Latest News

Sullivan & Cromwell, Wachtell steer Baxter's $10.5 billion Hill-Rom buy

Sullivan & Cromwell and Wachtell, Lipton, Rosen & Katz are crafting medical technology company Baxter International Inc’s plans to purchase competitor Hill-Rom Holdings Inc for roughly $10.5 billion in cash.

Medtech firm Baxter to buy hospital-bed maker Hill-Rom for $10.5 billion

U.S. medtech firm Baxter International Inc said on Thursday it would buy rival Hill-Rom Holdings Inc for about $10.5 billion, adding smart hospital beds to its portfolio of patient monitoring and diagnostic products.

Medtech firm Baxter to buy hospital-bed maker Hill-Rom for $10.5 bln

U.S. medtech firm Baxter International Inc said on Thursday it would buy rival Hill-Rom Holdings Inc for roughly $10.5 billion, adding smart hospital beds to its portfolio of patient monitoring and diagnostic products. (Reporting by Dania Nadeem in Bengaluru; Editing by...

Baxter in advanced talks to acquire Hill-Rom for $10 billion -source

U.S.-based medical technology company Baxter International Inc is nearing a deal to buy medical equipment maker Hill-Rom Holdings Inc for more than $10 billion, a person familiar with the matter said on Monday.

Baxter in advanced talks to acquire Hill-Rom for about $10 bln -WSJ

U.S.-based medical technology company Baxter International Inc is in advanced talks to buy medical equipment maker Hill-Rom Holdings Inc for about $10 billion, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

Moderna taps Baxter to support fill and finish of 60-90 million COVID-19 vaccine doses

Drugmaker Baxter International Inc will help fill in vials and package about 60-90 million doses of Moderna Inc's COVID-19 vaccine in 2021, the companies said on Monday.

Baxter to support fill and finish of 60-90 mln Moderna vaccine doses

Baxter International Inc will provide fill and finish sterile production services for about 60-90 million doses of Moderna Inc's COVID-19 vaccine in 2021, the companies said on Monday. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)

Baxter International beats shareholder claims over forex accounting

A Chicago federal judge dismissed a proposed class action against Baxter International Inc on Tuesday, writing that shareholders failed to claim the medical equipment company and its top executives knew the company was not accurately recording foreign transactions.

Baxter in $5 billion bid for Omnicell -sources

Medical supplies provider Baxter International Inc has approached medication management software vendor Omnicell Inc with an offer to acquire it for more than $5 billion, people familiar with the matter said on Tuesday.

BRIEF-Baxter Announces FDA Clearance Of Altapore Shape Bioactive Bone Graft For Use In Surgery

* BAXTER ANNOUNCES U.S. FDA CLEARANCE OF ALTAPORE SHAPE BIOACTIVE BONE GRAFT FOR USE IN SURGERY Source text for Eikon: Further company coverage:

BRIEF-Baxter Highlights New Data On Improving Care For Dialysis Patients

* BAXTER HIGHLIGHTS NEW DATA ON THE ROLE TECHNOLOGIES PLAY IN IMPROVING CARE FOR DIALYSIS PATIENTS DURING THE 57TH ERA-EDTA VIRTUAL CONGRESS

Mexico orders probe into alleged graft linked to ex-president

Mexican President Andres Manuel Lopez Obrador on Wednesday ordered an investigation into allegations the former government irregularly awarded lucrative contracts to a firm allegedly tied to the family of his predecessor, Enrique Pena Nieto.

BRIEF-Baxter Receives CE Marking For EVO IQ Syringe Infusion System

* BAXTER RECEIVES CE MARKING AND AUSTRALIAN REGULATORY APPROVAL FOR EVO IQ SYRINGE INFUSION SYSTEM, BUILDING ON SMART PUMP PLATFORM Source text for Eikon: Further company coverage:

BRIEF-Baxter Announces Results Of Clinical Trial On Benefits Of Dynamic Fluid Management In Septic Shock Patients

* BAXTER ANNOUNCES RESULTS OF CLINICAL TRIAL ON BENEFITS OF DYNAMIC FLUID MANAGEMENT IN SEPTIC SHOCK PATIENTS

BRIEF-Baxter Reports First-Quarter 2020 Results

* Q1 REVENUE $2.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.75 BILLION

BRIEF-Baxter Says Audit Committee To Continue To Actively Oversee Remedial Actions

* BAXTER - IN 2020, AUDIT COMMITTEE TO CONTINUE TO ACTIVELY OVERSEE REMEDIAL ACTIONS TO HELP ENSURE THAT EVENTS LEADING TO RESTATEMENT DO NOT RECUR

Baxter to hire 2,000 employees as demand for medical products surge

Baxter International Inc <BAX.N> said on Wednesday it would hire up to 2,000 employees globally, including 800 people in the United States, in response to higher demand for its medical devices due to rise in cases of the new coronavirus infections.

BRIEF-Baxter Provides Update On Covid-19 Response Efforts

* BAXTER INTERNATIONAL INC - HIRING UP TO 2,000 NEW EMPLOYEES GLOBALLY

Pfizer, Baxter defeat intravenous saline solutions antitrust case

A federal judge has dismissed a proposed class action accusing Baxter International and Pfizer Inc's Hospira of engaging in an anticompetitive scheme to restrict the output of intravenous saline solutions in order to boost prices.

BRIEF-Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format

* BAXTER TO HOST ITS ANNUAL MEETING OF STOCKHOLDERS IN VIRTUAL FORMAT Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up